The reason why lymphocytes of two HER2 3 + BC-M could induce anti-HER2 response remains unclear; however, high expression of HER2 on the cancer cells might activate HER2 specific memory B cells and plasma cells, while low expression of HER2 might be insufficient to induce such memory and plasma cells. Here, ERBB2 is linked to breast cancer.